Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Anti-estrogen medication reduces risk of dying from lung cancer

January 23, 2011 9:32 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) A new study has found that tamoxifen, an anti-estrogen breast cancer medication, may reduce an individual's risk of death from lung cancer. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study supports the hypothesis that...

HEPA filters reduce cardiovascular health risks associated with air pollution

January 21, 2011 8:34 am | by EurekAlert | News | Comments

(American Thoracic Society) Using inexpensive air filters may help reduce cardiovascular disease risk that results from exposure to air pollution, according to researchers from Canada, who studied healthy adults living in a small community in British Columbia where wood burning stoves are...

Awake despite anesthesia

January 20, 2011 12:34 pm | by EurekAlert | News | Comments

(Deutsches Aerzteblatt International) Unintended awareness during surgery is classified as an occasional complication of anesthesia (one to two in 1,000 patients) -- but being aware of things happening during the operation, and being able to recall them later, can leave a patient with...

Advertisement

Covidien Announces Launch of Puritan Bennett(TM) 520 Portable Ventilator in Europe

January 19, 2011 11:34 pm | by Covidien | News | Comments

New, easy-to-use mobile respiratory device provides ventilation option for patients transitioning from the hospital to the home BOULDER, Colo., Jan 20, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical...

NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump® and ResQPOD® CPR D...

January 19, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

ROSEVILLE, Minn., Jan. 19, 2011 /- A combination of two devices could save the lives of thousands of cardiac arrest patients each year if implemented nationwide, suggests clinical trial results published in today's online edition of The Lancet. A significantly higher percentage of...

ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbineâ„¢ NDA

January 19, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Jan. 19, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) announced today that the U.S. Food and Drug Administration (FDA) has established a Prescription Drug User Fee Act (PDUFA) date of September 1, 2011 for the review of the Exelbine (ANX-530) New Drug Application...

Bus and tram passengers warned to keep their germs to themselves

January 18, 2011 12:37 pm | by EurekAlert | News | Comments

(University of Nottingham) You are six times more likely to end up at the doctors with an acute respiratory infection if you have recently used a bus or tram -- but those who use buses or trams daily might well be somewhat protected compared with more occasional users.

Findings on pollution damage to human airways could yield new therapies

January 17, 2011 8:34 pm | by EurekAlert | News | Comments

(Duke University Medical Center) Researchers from Duke University Medical Center have identified how nanoparticles from diesel exhaust damage lung airway cells, a finding that could lead to new therapies for people susceptible to airway disease. The scientists also discovered that the...

Advertisement

Financing Demonstrates Faith in Surgical Sleep Apnea Treatment

January 16, 2011 10:36 pm | by San Diego Business Journal | News | Comments

A San Diego device maker has put to bed more than $8 million of funding to test and develop a pacemakerlike device that could help some sleep apnea sufferers get relief without relying on air masks.

'A stark warning:' Smoking causes genetic damage within minutes after inhaling

January 15, 2011 5:36 pm | by EurekAlert | News | Comments

(American Chemical Society) In research described as "a stark warning" to those tempted to start smoking, scientists are reporting that cigarette smoke begins to cause genetic damage within minutes -- not years -- after inhalation into the lungs. Their report, the first human study to...

Dr. Peter J. Pronovost to Join the Board of Directors of Cantel Medical Corp.

January 13, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

LITTLE FALLS, N.J., Jan. 13, 2011 /- Cantel Medical Corp. (NYSE: CMN ) today announced the election of Peter J. Pronovost, M.D., Ph.D. to serve as an independent member of Cantel's Board of Directors. "Dr. Pronovost is a world renowned leader of patient safety and quality, serving as a...

HASCO Medical Signs Agreement With the State of Alabama

January 13, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

MOBILE, Ala., Jan. 13, 2011 /- HASCO Medical, Inc. (OTC Bulletin Board: HASC ), www.mysouthernmed.com , a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, today announced that Southern Medical & Mobility (SMM), a wholly owned subsidiary of HASCO...

K-V Pharmaceutical Company Updates Status of New Drug Application for Gestivaâ„¢

January 12, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Jan. 12, 2011 /- K-V Pharmaceutical Company (NYSE:  KVa/KVb) today issued an update on the status of the U.S. Food and Drug Administration's review of Hologic, Inc.'s (Hologic) New Drug Application (NDA) for Gestiva™ (hydroxyprogesterone caproate injection) as a...

Advertisement

Syndax Announces Publication of Entinostat NSCLC Data in Cancer Research

January 11, 2011 11:35 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., Jan. 11, 2011 /- Syndax, a clinical-stage epigenetics oncology company, announced publication of data of entinostat combined with the demethylating agent Vidaza® (azacitidine) showing effect in reducing tumor burden in differentiated tumor cells in animal tumor models...

Dehaier Medical Announces Participation in Arab Health 2011

January 11, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

BEIJING, Jan. 11, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it will...

New research aims to shut down viral assembly line

January 11, 2011 4:33 am | by EurekAlert | News | Comments

(Arizona State University) Brenda Hogue and her colleagues at the Biodesign Institute at Arizona State University are studying the intricate formation of coronaviruses. The research may provide fresh insights leading to antiviral agents against viral pathogens like SARS.

Mayo researchers describe measles viral protein movement

January 9, 2011 9:32 am | by EurekAlert | News | Comments

(Mayo Clinic) Mayo Clinic researchers have shown that proteins on the surface of a cell twist a viral protein into position, allowing the virus to start infection and cause disease, all in a movement as graceful as a ballroom dance.

Nonin Medical Announces Microsoft® HealthVaultâ„¢ Certification of Worldâ??s First Continuaâ„¢-Certified, Bluetooth® Wireless Fingertip Pulse Oximeter at CES 2011

January 6, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Jan. 6, 2011 /- Nonin Medical, Inc., the inventor of fingertip pulse oximetry and a leader in noninvasive physiological monitoring, today announced that the Onyx® II Model 9560 Continua™-Certified, Bluetooth® wireless fingertip pulse oximeter has received...

Vapotherm, Inc. Announces CE Mark Approval for Flowrest® Homecare Device

January 6, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

STEVENSVILLE, Md., Jan. 6, 2011 /PRNewswire-USNewswire/ -- Vapotherm, the global leader in High Flow Therapy products, announced receiving CE marking for Flowrest®, a device designed for homecare and other low acuity environments. The Flowrest® device delivers warmed humidified...

Covidien Announces the Availability of Nellcor(TM) OxiMax(TM) SpO2 Technology with Dräger Infinity(R) Acute Care Systemin Europe

January 5, 2011 4:33 pm | by Covidien | News | Comments

BOULDER, Colo., Jan 05, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today announced the availability of the new Infinity(R) MCable(R) with Nellcor(TM)...

Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.

January 5, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

MIAMI, Jan. 5, 2011 /- The Alpha-1 Foundation announced today that it has awarded two research grants to investigators whose research will contribute to our understanding of the causes and mechanisms that give rise to lung disease. The first grant will investigate how cigarette smoke...

InterMune to Present at J.P. Morgan Healthcare Conference

January 5, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

BRISBANE, Calif., Jan. 5, 2011 /- InterMune, Inc. (Nasdaq: ITMN ) today announced that Dan Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco on January 12, 2011, at 4:30 p.m. EST / 1:30...

Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA Article(2)

January 4, 2011 12:35 pm | by Boston Scientific | News | Comments

NATICK, Mass., Jan. 4, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today issued the following statement from Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, on an article that was pub

PneumRx, Inc. Raises $33 Million in Capital

January 4, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Jan. 4, 2011 /- PneumRx, Inc. ( www.pneumrx.com ), a medical device company dedicated to bringing innovation and improvements to the treatment of lung disease, today announced that it has raised $33 million in working capital commitments.  The oversubscribed...

Accuray Elevated to NASDAQ Global Select Market

January 3, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Jan. 3, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that it has been named to the NASDAQ Global Select Market, the premier listing tier for NASDAQ companies. The NASDAQ Global Select Market is designated...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading